Literature DB >> 22107879

Attitudes of methadone program staff toward provision of harm-reduction and other services.

Sherry Deren1, Sung-Yeon Kang, Milton Mino, Randy M Seewald.   

Abstract

OBJECTIVE: The need for expansion of health services provided in drug treatment programs has been widely discussed since the beginning of the HIV epidemic among drug users. Service expansion has focused on various types of services including medical services (eg, primary care) and harm-reduction services (eg, provision of sterile syringes).
METHODS: A staff survey was conducted in 8 methadone maintenance clinics in the New York/New Jersey area to assess attitudes toward the provision of harm reduction and other services in methadone clinics, and the relationship of these attitudes to other variables. PARTICIPANTS: A total of 114 staff members in 8 methadone maintenance clinics completed the survey.
RESULTS: The majority of staff was supportive of adding services, over 90% supported medical services, and the majority supported harm-reduction services such as syringe access and disposal services. Higher education and HIV knowledge levels were significant correlates of favorable attitudes toward service provision.
CONCLUSIONS: Support for providing harm-reduction services in methadone maintenance clinics was found. Enhancing knowledge of staff regarding various types of health services, and engaging them in how best to institute new services, should be undertaken when new services are planned.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22107879      PMCID: PMC3223376          DOI: 10.1097/ADM.0b013e31821dc61a

Source DB:  PubMed          Journal:  J Addict Med        ISSN: 1932-0620            Impact factor:   3.702


  10 in total

1.  Engaging the HIV-infected substance abuse--the classic academic approach to changing clinical practice: excruciatingly slow, extraneous, and/or effective?

Authors:  J H Samet
Journal:  MedGenMed       Date:  2001-03-30

2.  Assessing organizational readiness for change.

Authors:  Wayne E K Lehman; Jack M Greener; D Dwayne Simpson
Journal:  J Subst Abuse Treat       Date:  2002-06

3.  Gaps in the drug-free and methadone treatment program response to Hepatitis C.

Authors:  Shiela M Strauss; Janetta Astone; Zdravko P Vassilev; Don C Des Jarlais; Holly Hagan
Journal:  J Subst Abuse Treat       Date:  2003-06

4.  Challenges in recruiting and training drug treatment patients as peer outreach workers: a perspective from the field.

Authors:  Rosa M Colón; Sherry Deren; Honoria Guarino; Milton Mino; Sung-Yeon Kang
Journal:  Subst Use Misuse       Date:  2010-10       Impact factor: 2.164

5.  Changes in injecting practices associated with the use of a medically supervised safer injection facility.

Authors:  Jo-Anne Stoltz; Evan Wood; Will Small; Kathy Li; Mark Tyndall; Julio Montaner; Thomas Kerr
Journal:  J Public Health (Oxf)       Date:  2007-01-17       Impact factor: 2.341

6.  Needle exchange use among a cohort of injecting drug users.

Authors:  E E Schoenbaum; D M Hartel; M N Gourevitch
Journal:  AIDS       Date:  1996-12       Impact factor: 4.177

7.  Conducting peer outreach to migrants: outcomes for drug treatment patients.

Authors:  Sherry Deren; Sung-Yeon Kang; Milton Mino; Honoria Guarino
Journal:  J Immigr Minor Health       Date:  2012-04

8.  Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program.

Authors:  P A Selwyn; N S Budner; W C Wasserman; P S Arno
Journal:  Public Health Rep       Date:  1993 Jul-Aug       Impact factor: 2.792

9.  Sterile syringe access and disposal among injection drug users newly enrolled in methadone maintenance treatment: a cross-sectional survey.

Authors:  Jennifer McNeely; Julia H Arnsten; Marc N Gourevitch
Journal:  Harm Reduct J       Date:  2006-02-18

10.  Opiate users' knowledge about overdose prevention and naloxone in New York City: a focus group study.

Authors:  Nancy Worthington; Tinka Markham Piper; Sandro Galea; David Rosenthal
Journal:  Harm Reduct J       Date:  2006-07-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.